Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Index by author

February 01, 2000; Volume 67,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Markman, Maurie

    1. You have access
      Brain metastases: Presentation, evaluation, and management
      Mark A. Chidel, MD, John H. Suh, MD and Gene H. Barnett, MD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 120-127;

      Prompt diagnosis and treatment can prolong the patient’s life and improve the quality of his or her remaining days.

  2. Mossad, Sherif B.

    1. You have access
      Antiviral agents for treating influenza
      Jennifer K. Long, PHARMD, Sherif B. Mossad, MD and Morton P. Goldman, PHARMD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 92-95;

      We now have four antiviral drugs for treating influenza. Who should receive them? Which one to use?

  3. Novy, Margareta

    1. Are strict vegetarians at risk of vitamin B<sub>12</sub> deficiency?
      You have access
      Are strict vegetarians at risk of vitamin B12 deficiency?
      Margareta Novy, MPH, RD, LD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 87;

      Patients who avoid or limit animal products in their diets should be encouraged to take vitamin B12 supplements or eat fortified foods.

  4. Roe, Matthew T.

    1. You have access
      Glycoprotein Ilb/IIIa inhibitors in acute coronary syndromes
      Matthew T. Roe, MD, Shelly K. Sapp, MS and A. Michael Lincoff, MD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 131-140;

      These potent antiplatelet agents constitute a breakthrough, hut questions remain about their safety, cost-effectiveness, and proper empiric use. With an illustration explaining the paradoxical prothrombotic effect of fibrinolytic drugs.

  5. Saadeh, Sherif

    1. You have access
      The spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitis
      Sherif Saadeh, MD and Zobair M. Younossi, MD, MPH
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 96-104;

      This recently discovered disease is a common cause of elevated liver enzymes. We are beginning to understand which patients are at greatest risk of progressive liver disease.

  6. Sapp, Shelly K.

    1. You have access
      Glycoprotein Ilb/IIIa inhibitors in acute coronary syndromes
      Matthew T. Roe, MD, Shelly K. Sapp, MS and A. Michael Lincoff, MD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 131-140;

      These potent antiplatelet agents constitute a breakthrough, hut questions remain about their safety, cost-effectiveness, and proper empiric use. With an illustration explaining the paradoxical prothrombotic effect of fibrinolytic drugs.

  7. Suh, John H.

    1. You have access
      Brain metastases: Presentation, evaluation, and management
      Mark A. Chidel, MD, John H. Suh, MD and Gene H. Barnett, MD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 120-127;

      Prompt diagnosis and treatment can prolong the patient’s life and improve the quality of his or her remaining days.

  8. Vidt, Donald G.

    1. You have access
      Is there an advantage to combination therapy with ACE inhibitors and angiotensin II-receptor blockers?
      Donald G. Vidt, MD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 89-91;

      Theoretic reasons and small studies suggest the two types of drugs may be useful in combination, but a definitive answer awaits the results of larger studies.

  9. Wilke, William S.

    1. You have access
      Is God good for your health? The role of spirituality in medical care
      David B. Larson, MD, MSPH and Harold G. Koenig, MD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 80-84;

      Many studies found that religious belief and practice have a positive effect on physical and mental health. Physicians should try to understand and respect their patients’ beliefs.

    2. You have access
      Antiviral agents for treating influenza
      Jennifer K. Long, PHARMD, Sherif B. Mossad, MD and Morton P. Goldman, PHARMD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 92-95;

      We now have four antiviral drugs for treating influenza. Who should receive them? Which one to use?

  10. Younossi, Zobair M.

    1. You have access
      The spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitis
      Sherif Saadeh, MD and Zobair M. Younossi, MD, MPH
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 96-104;

      This recently discovered disease is a common cause of elevated liver enzymes. We are beginning to understand which patients are at greatest risk of progressive liver disease.

« Previous (Pages : 1 2 ... 2)next »
Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 67 (2)
Cleveland Clinic Journal of Medicine
Vol. 67, Issue 2
1 Feb 2000
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Sign up for alerts
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
  • Meta-analysis: Its strengths and limitations
  • Primary angiitis of the central nervous system: diagnostic criteria and clinical approach
  • Role of uric acid in hypertension, renal disease, and metabolic syndrome
  • Frailty in older adults: Implications for end-of-life care
  • The essential role of exercise in the management of type 2 diabetes
More...

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire